Latest News and Press Releases

Borregaard’s operating revenues were NOK 1,949 million (NOK 1,714 million)2 in the 3rd quarter of 2024. EBITDA1 reached NOK 524 million (NOK 482 million). The result in both BioSolutions and Fine...

23 October 2024: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q3 2024 results Borregaard will report third quarter 2024 results on Wednesday 30 October 2024 at 07:00 CET. A stock...

Borregaard and the Norwegian hydropower producer Hafslund have entered into a new long-term power purchase agreement, for the period 2025 to 2034. The annual contract volume is 88 GWh, representing...

Borregaard’s Capital Markets Day (CMD) will take place today at Oslo Concert Hall, starting at 09:00 and ending at 12:30 CEST. The event can be followed via webcast...

Today, Sveinung Heggen, General Counsel, exercised 15,000 stock options at a strike price of NOK 87.60 per share and in separate transactions, purchased and sold the same number of shares. The...

Borregaard’s operating revenues were NOK 1,949 million (NOK 1,963 million)2 in the 2nd quarter of 2024. EBITDA1 was NOK 510 million (NOK 537 million). The result in BioSolutions increased while the...

10 July 2024: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q2 2024 results Borregaard will report second quarter 2024 results on Wednesday 17 July 2024 at 07:00 CEST. A stock...

On 21 June 2024, the Financial Supervisory Authority of Norway approved the prospectus prepared by Borregaard in connection with the listing on the Oslo Stock Exchange of the Company’s bonds with ISIN...

Borregaard has participated with its fully diluted pro-rata share (35%) in the NOK 400 million capital raise in the marine biotech company Alginor to fund the next step of the biorefinery expansion....

Borregaard ASA has issued a commercial paper ISIN NO0013264598 of NOK 200,000,000. Start date: 18 June, 2024Maturity: 18 September, 2024Coupon: 4,97 %Organised by: DNB MarketsSarpsborg, 14 June...